Accurate, accessible and
affordable disease diagnostics
to improve global health.
The right decision-making, treatment and our health depend on accurate diagnosis on time, yet we face limited access, high inefficiency and high costs.
3 700 000 000
people have limited access to critical diagnostics today.
Unique, highly multiplexed and low-cost sensing technology based on state-of-the-art R&D
Our patent protected technology has been developed through +10 years of state-of-the-art biochemistry and nanotechnology R&D. With our isothermal amplification and unique biosensing method, we enable highly multiplexed and low-cost detection of biomarkers directly at the point of care.
Unique, highly multiplexed and low-cost sensing technology based on state-of-the-art R&D
First point-of-care solution for dual nucleic acid and protein detection, applicable for different disease areas.
High-accuracy multiplexing for accurate diagnosis and improved clinical outcome.
Rapid results in minutes, instead of days, for faster decision-making and treatment.
Team members
Maria Barklund
Co-founder & CEO
Petter Barreng
Co-founder & CTO
Aldo Jesorka
Co-founder, Professor Chemistry and Chemical Engineering
Maria Strömme
Co-founder, Professor Nanotechnology
Teresa Zardán Gómez de la Torre
Co-founder & Senior Scientist, Assistant Professor Nanotechnology
Sobhan Sepehri
Co-founder, PhD Microtechnology and Nanoscience
Dag Winkler
Co-founder, Professor Microtechnology and Nanoscience
Matilda Wassbjer
QA/RA Manager, MSc. Engineering biology
Felicia Björklund
Sensor Engineer, MSc. Engineering biology
Kristina Reklev
Lab Engineer, MSc. Biomedical science
Walter Rangel Campos
VP of Business Development, MBA, PhD Virology
View open positions
Trusted partners
